Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R John

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failureM R John, W G Goodman, P Gao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 1997
Solid phase competitive luminescence immunoassay for immunoglobulin A in faeces: development and clinical validationE Schoof, M R John, B Arndt, et al.
Zeitschrift Fur Gastroenterologie|July 24, 1998
Validity of new immunological human fecal hemoglobin and albumin tests in detecting colorectal neoplasms--an endoscopy-controlled studyA Sieg, M Scheida, M R John, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 24, 2001
Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid functionP Gao, S Scheibel, P D'Amour, et al.
Osteoarthritis and Cartilage|November 7, 2012
Direct comparison of fixed flexion, radiography and MRI in knee osteoarthritis: responsiveness data from the Osteoarthritis InitiativeW Wirth, J Duryea, M-P Hellio Le Graverand, et al.
Bone|October 12, 2001
A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannomaM R John, H Wickert, K Zaar, et al.
Journal of Clinical Pharmacology|July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trialsM A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Osteoarthritis and Cartilage|May 6, 2014
Trajectory of cartilage loss within 4 years of knee replacement--a nested case-control study from the osteoarthritis initiativeF Eckstein, R M Boudreau, Z Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failureM R John, W G Goodman, P Gao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 1997
Solid phase competitive luminescence immunoassay for immunoglobulin A in faeces: development and clinical validationE Schoof, M R John, B Arndt, et al.
Zeitschrift Fur Gastroenterologie|July 24, 1998
Validity of new immunological human fecal hemoglobin and albumin tests in detecting colorectal neoplasms--an endoscopy-controlled studyA Sieg, M Scheida, M R John, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 24, 2001
Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid functionP Gao, S Scheibel, P D'Amour, et al.
Osteoarthritis and Cartilage|November 7, 2012
Direct comparison of fixed flexion, radiography and MRI in knee osteoarthritis: responsiveness data from the Osteoarthritis InitiativeW Wirth, J Duryea, M-P Hellio Le Graverand, et al.
Bone|October 12, 2001
A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannomaM R John, H Wickert, K Zaar, et al.
Journal of Clinical Pharmacology|July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trialsM A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Osteoarthritis and Cartilage|May 6, 2014
Trajectory of cartilage loss within 4 years of knee replacement--a nested case-control study from the osteoarthritis initiativeF Eckstein, R M Boudreau, Z Wang, et al.
Pageof 2